340B Rebate Model Pilot Program
Ten manufacturers’ plans have been approved to participate in the 340B Rebate Model Pilot Program. Consistent with HRSA’s statutory authority under the 340B Program, the Pilot provides a rebate mechanism through which qualifying manufacturers may effectuate the 340B ceiling price for certain drugs sold to covered entities.
The Pilot is limited to a select group of drugs and is open to qualifying manufacturers that submitted plans meeting specific criteria. For more details on the Pilot, please visit Notice Regarding 340B Rebate Model Pilot Program. (PDF - 316 KB)
The 340B Rebate Model Pilot Program webpage provides detailed information on the approved plans and Frequently Asked Questions for 340B Program stakeholders.
Guidance to 340B providers in Alabama, Florida, Hawaii, Washington, the Commonwealth of the Northern Mariana Islands, and the Territory of Guam
Public health emergency declaration by the Secretary
We recognize that circumstances surrounding disaster relief efforts warrant flexibility for entities eligible for participation in the 340B Program. Therefore, eligible entities in Alabama, Florida, Hawaii, Washington, the Commonwealth of the Northern Mariana Islands, and the Territory of Guam may immediately enroll for the 340B Program during the Public Health Emergency Declaration by the Secretary, rather than having to wait for the normal quarterly registration period. We believe this will enable these entities to meet the needs of the residents affected by these disasters.
Contact: If you are in the listed states and would like to enroll, email the 340B Prime Vendor Program or call 1-888-340-2787.